IL6 and cardiovascular disorder: While prior studies in SSA have found elevated CRP, IL-6, and other markers of systemic inflammation which were associated with increased mortality and cardiovascular disease [54–58], there is a clear need for data on the relationship of inflammation with metabolic comorbidities.